• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类脓毒症休克。对发病机制、心血管功能障碍及治疗认识的进展。

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

作者信息

Parrillo J E, Parker M M, Natanson C, Suffredini A F, Danner R L, Cunnion R E, Ognibene F P

机构信息

Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612.

出版信息

Ann Intern Med. 1990 Aug 1;113(3):227-42. doi: 10.7326/0003-4819-113-3-227.

DOI:10.7326/0003-4819-113-3-227
PMID:2197912
Abstract

Septic shock is the commonest cause of death in intensive care units. Although sepsis usually produces a low systemic vascular resistance and elevated cardiac output, strong evidence (decreased ejection fraction and reduced response to fluid administration) suggests that the ventricular myocardium is depressed and the ventricle dilated. In survivors, these abnormalities are reversible. Failure to develop ventricular dilatation in nonsurvivors suggests that dilatation is a compensatory mechanism needed to maintain adequate cardiac output. With a canine model of septic shock that is very similar to human sepsis, myocardial depression was confirmed using load-independent measures of ventricular performance. Endotoxin administration to humans simulates the qualitative, cardiovascular abnormalities of sepsis. The pathogenesis of septic shock is extraordinarily complex. Diverse microorganisms can generate toxins, stimulating release of potent mediators that act on vasculature and myocardium. A circulating myocardial depressant substance has been closely associated with the myocardial depression of human septic shock. Therapy has emphasized early use of antibiotics, critical care monitoring, aggressive volume resuscitation, and, if shock continues, use of inotropic agents and vasopressors. Pharmacologic or immunologic antagonism of endotoxin or other mediators may prove to enhance survival in this highly lethal syndrome.

摘要

感染性休克是重症监护病房中最常见的死亡原因。尽管脓毒症通常会导致全身血管阻力降低和心输出量增加,但有力证据(射血分数降低以及对液体输注反应减弱)表明心室心肌功能受到抑制且心室扩张。在幸存者中,这些异常情况是可逆的。非幸存者未出现心室扩张表明扩张是维持足够心输出量所需的一种代偿机制。通过一种与人类脓毒症非常相似的犬类感染性休克模型,使用不依赖负荷的心室功能测量方法证实了心肌抑制。给人类注射内毒素可模拟脓毒症在心血管方面的定性异常。感染性休克的发病机制极其复杂。多种微生物可产生毒素,刺激强效介质的释放,这些介质作用于血管系统和心肌。一种循环性心肌抑制物质与人类感染性休克的心肌抑制密切相关。治疗重点在于早期使用抗生素、重症监护监测、积极的容量复苏,以及在休克持续时使用强心剂和血管升压药。对内毒素或其他介质进行药理或免疫拮抗可能会提高这种高致死性综合征的生存率。

相似文献

1
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.人类脓毒症休克。对发病机制、心血管功能障碍及治疗认识的进展。
Ann Intern Med. 1990 Aug 1;113(3):227-42. doi: 10.7326/0003-4819-113-3-227.
2
Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock.脓毒症和脓毒性休克中的全身血流动力学异常及血管活性药物治疗
Am J Kidney Dis. 1992 Sep;20(3):214-22. doi: 10.1016/s0272-6386(12)80693-7.
3
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.犬类的内毒素和肿瘤坏死因子激发试验模拟了人类感染性休克的心血管特征。
J Exp Med. 1989 Mar 1;169(3):823-32. doi: 10.1084/jem.169.3.823.
4
Myocardial dysfunction in septic shock.感染性休克中的心肌功能障碍
Crit Care Clin. 2000 Apr;16(2):251-87. doi: 10.1016/s0749-0704(05)70110-x.
5
Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans.与左心室变化相似,右心室功能障碍和扩张是人类脓毒性休克时心脏抑制的特征。
Chest. 1990 Jan;97(1):126-31. doi: 10.1378/chest.97.1.126.
6
Pathophysiology of cardiovascular dysfunction in septic shock.脓毒症休克中心血管功能障碍的病理生理学
New Horiz. 1998 May;6(2):130-8.
7
New perspectives on the management of septic shock in the cancer patient.癌症患者感染性休克管理的新视角。
Infect Dis Clin North Am. 1996 Jun;10(2):239-53. doi: 10.1016/s0891-5520(05)70298-1.
8
Myocardial dysfunction in sepsis.脓毒症中的心肌功能障碍
Crit Care Clin. 1989 Jan;5(1):99-118.
9
[Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].[脉搏指示连续心输出量监测在脓毒症休克患者心功能评估中的价值:一项前瞻性研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Jan;27(1):22-7. doi: 10.3760/cma.j.issn.2095-4352.2015.01.006.
10
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.革兰氏阴性菌血症在模拟人类感染性休克的犬类模型中会导致严重的收缩期和舒张期心脏功能障碍。
J Clin Invest. 1986 Jul;78(1):259-70. doi: 10.1172/JCI112559.

引用本文的文献

1
Reversible Myocardial Depression and Dilatation in COVID-19 Shock Patients.新型冠状病毒肺炎休克患者的可逆性心肌抑制和扩张
Crit Care Explor. 2025 Jun 13;7(6):e1264. doi: 10.1097/CCE.0000000000001264. eCollection 2025 Jun 1.
2
Impact of Venous CONgestion on Organ Function and Outcomes in Sepsis (ICON-Sepsis): a prospective observational cohort study protocol.静脉淤血对脓毒症器官功能及预后的影响(ICON-脓毒症):一项前瞻性观察性队列研究方案
BMJ Open. 2025 Jun 8;15(6):e098987. doi: 10.1136/bmjopen-2025-098987.
3
Immunomodulatory and cardio-protective effects of differentially originated multipotent mesenchymal stroma cells during polymicrobial sepsis in mice.
不同来源的多能间充质基质细胞在小鼠多微生物败血症期间的免疫调节和心脏保护作用。
Eur J Trauma Emerg Surg. 2025 Apr 20;51(1):178. doi: 10.1007/s00068-025-02862-2.
4
Integrated bioinformatics and experiment validation reveal cuproptosis-related biomarkers and therapeutic targets in sepsis-induced myocardial dysfunction.整合生物信息学与实验验证揭示脓毒症诱导的心肌功能障碍中与铜死亡相关的生物标志物和治疗靶点。
BMC Infect Dis. 2025 Mar 31;25(1):445. doi: 10.1186/s12879-025-10822-9.
5
MEGF9 prevents lipopolysaccharide-induced cardiac dysfunction through activating AMPK pathway.MEGF9通过激活AMPK信号通路预防脂多糖诱导的心脏功能障碍。
Redox Rep. 2025 Dec;30(1):2435252. doi: 10.1080/13510002.2024.2435252. Epub 2024 Dec 31.
6
Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis.铁死亡抑制因子-1通过受损的趋化因子轴抑制中性粒细胞浸润,从而改善急性脓毒症诱导的心肌病。
Front Cell Dev Biol. 2024 Dec 12;12:1510232. doi: 10.3389/fcell.2024.1510232. eCollection 2024.
7
Trends in sepsis-associated cardiovascular disease mortality in the United States, 1999 to 2022.1999年至2022年美国脓毒症相关心血管疾病死亡率的趋势
Front Cardiovasc Med. 2024 Dec 9;11:1505905. doi: 10.3389/fcvm.2024.1505905. eCollection 2024.
8
The Potential Predictive Role of Oxidative Stress and Antioxidant Parameters Regarding Mortality and the Type of Causative Agent in Sepsis.氧化应激和抗氧化参数对脓毒症死亡率及病原体类型的潜在预测作用
Cureus. 2024 Nov 11;16(11):e73456. doi: 10.7759/cureus.73456. eCollection 2024 Nov.
9
Diagnostic and Prognostic Value of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) for Septic Cardiomyopathy.髓系细胞触发受体-1(sTREM-1)对脓毒症性心肌病的诊断和预后价值
J Inflamm Res. 2024 Oct 29;17:7869-7879. doi: 10.2147/JIR.S481792. eCollection 2024.
10
Relationships between human serum albumin levels and septic shock, in-hospital, and out-of-hospital mortality in elderly patients with pneumonia in different BMI ranges.不同BMI范围内老年肺炎患者血清白蛋白水平与感染性休克、院内及院外死亡率之间的关系。
Pneumonia (Nathan). 2024 Sep 25;16(1):17. doi: 10.1186/s41479-024-00138-8.